Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angelalign Technology has established itself as a leading provider of clear aligner solutions since its founding in 2003. The company operates globally across more than 50 countries and continues to expand manufacturing capacity, including a new advanced facility in the US. Its products are widely used by dental professionals for orthodontic treatments, with strong support for clinical research and digital innovation. Clinical results are regularly published in international journals through KOL-led studies demonstrating efficacy and workflow improvements. The company’s main product line—Angel Aligner Pro—offers custom-made removable clear orthodontic devices supported by proprietary digital case assessment and treatment planning tools. No specific drug or biologic clinical trials are reported; all offerings are commercialized medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Angelalign Technology.